Trial Masters joins ZEINCRO to create specialist CRO in Central- and South-Eastern Europe
Athens, Greece and Budapest, Hungary – 11 June 2012 – ZEINCRO, a specialist provider of clinical research services in Greece, Turkey and Cyprus, today announced it is consolidating with Trial Masters Ltd, a contract research organisation managing clinical trials in Hungary and Romania.
With a team of more than 140 people and over a decade's experience, the expanded ZEINCRO Group, will be ideally positioned to offer to its global drug development customers clinical trial services in a broader geographical region in Central- and South- Eastern Europe (CSEE).
"Adding Trial Masters to ZEINCRO Group will extend our geographic reach and allow us to work on larger-scale projects," commented Prof. Gregory Sivolapenko, Chairman of ZEINCRO Group. "Both our teams have forged strong links with local authorities and the healthcare community, giving us a unique and in-depth understanding of the regions in which we operate and enabling us to deliver bespoke clinical research services that are flexible and ethical, maximising patient recruitment and compliance."
Supplementary to clinical research services in CSEE, ZEINCRO Group provides specialised services in risk management plans, pharmacovigilance, post-marketing safety and efficacy studies as well as regulatory affairs.
Trial Masters CEO, Dr János Demeter, added: "We are excited to be joining ZEINCRO Group. This is a natural fit as we both share the same core values and fundamental approach to successfully delivering clinical development programmes. As we continue our local presence but also become part of a larger organisation, we will be able to enhance the support we offer to our customers."
ZEINCRO is a contract research organisation (CRO) specialist in Central- and South-Eastern European with a particular focus in Greece, Cyprus, Turkey, Hungary and Romania.
With over a decade's experience in successful clinical research projects in the region, the 140 ZEINCRO employees have developed a thorough understanding of the communities and the regions in which they operate and have established strong professional links with their local healthcare stakeholders. This approach allows ZEINCRO to set new standards for successful clinical trials by delivering bespoke services that are flexible, ethical and maximise patient recruitment and compliance.
ZEINCRO provides clinical trial services to the global drug development industry and offers complementary services in risk management plans, pharmacovigilance, post-marketing safety and efficacy studies as well as regulatory affairs.
For more information, visit www.zeincro.com or www.trialmasters.eu
For more information, please contact:
Takis Zervakakis, VP Marketing & Business Development
+30 210 8047709
For media enquiries, please contact:
College Hill Life Sciences
Lynne Trowbridge, Anastasios Koutsos, Henry Stanley
+44 20 7457 2020